Sandra Stubbs-Hervas
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
The potential of phytomedicines to optimize CAR-T cell therapy in cancer.
Journal: Immunotherapy
Published: September 19, 2025
Evaluation of methods to increase the expression of cytokine-induced killer cell chemoattractant cytokines in pancreatic cancer.
Journal: Gene therapy
Published: April 02, 2025
Inhibition of T cell infiltration and soluble TNF signaling is neuroprotective in the alpha-synuclein overexpressing mouse model of Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: March 18, 2025
Phosphatidylserine as a tumor target for CAR-T cell therapy.
Journal: Journal for immunotherapy of cancer
Published: February 03, 2025
Activation of central cannabinoid type 2 receptors, but not on peripheral immune cells, is required for endocannabinoid-mediated neuroprotection in Parkinson's disease.
Journal: Brain, behavior, and immunity
Published: December 16, 2024
Cell-specific delivery of CRISPR-Cas9 with pseudotyped lentiviral particles: Just change the envelope.
Journal: Molecular therapy. Nucleic acids
Published: December 13, 2024
Human T cells engineered with an HLA-A2-restricted murine T-cell receptor targeting glypican 3 effectively control human hepatocellular carcinoma in mice.
Journal: Hepatology (Baltimore, Md.)
Published: July 23, 2024
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model.
Journal: Journal for immunotherapy of cancer
Published: June 10, 2024
Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies.
Journal: Human vaccines & immunotherapeutics
Published: February 12, 2024
Last Updated: 09/26/2026